title: Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema.
authors.forename: Dagmar
authors.initials: D
authors.lastname: Simon
authors.forename: Jennifer
authors.initials: J
authors.lastname: Wittwer
authors.forename: Ganna
authors.initials: G
authors.lastname: Kostylina
authors.forename: Urs
authors.initials: U
authors.lastname: Buettiker
authors.forename: Hans-Uwe
authors.initials: HU
authors.lastname: Simon
authors.forename: Nikhil
authors.initials: N
authors.lastname: Yawalkar
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000077944:Alefacept; D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology*; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012333:RNA, Messenger / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016176:T-Lymphocyte Subsets / Q000276:immunology* / Q000378:metabolism
chemical_list: D000305:Adrenal Cortex Hormones; D016207:Cytokines; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D000077944:Alefacept